Details of the Drug

General Information of Drug (ID: DM7ZH8Z)

• Drug Name: Noribogaine
• Synonyms: CHEMBL343956; RAUCDOKTMDOIPF-NYRFGNLRSA-N; BDBM50067814; 17-ethyl-(1R,17S)-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraen-7-ol (noribogaine)

Indication

Disease Entry	ICD 11	Status	REF
Opioid dependence	6C43.2Z	Phase 2	[1]

• Chemical Identifiers:
  Formula: C19H24N2O
  Canonical SMILES: CCC1CC2CC3C1N(C2)CCC4=C3NC5=C4C=C(C=C5)O
  InChI: InChI=1S/C19H24N2O/c1-2-12-7-11-8-16-18-14(5-6-21(10-11)19(12)16)15-9-13(22)3-4-17(15)20-18/h3-4,9,11-12,16,19-20,22H,2,5-8,10H2,1H3/t11-,12+,16+,19+/m1/s1
  InChIKey: RAUCDOKTMDOIPF-RYRUWHOVSA-N
• Cross-matching ID:
  PubChem CID: 3083548
  ChEBI ID: CHEMBL146264
  CAS Number: 481-88-9
  TTD ID: D0R6TY
• Drug-Molecule Activity Atlas (DMA)NEW: Click to Jump to the Detailed DMA Information of This Drug

References

• [1] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)